Skip to main content

and
  1. No Access

    Article

    Aprepitant, fosaprepitant and risk of ifosfamide-induced neurotoxicity: a systematic review

    Ifosfamide is one of the chemotherapy regimens which potentially causes neurotoxicity in patients up to 30%. Aprepitant is administered as an anti-emetic agent in chemotherapy and regarding the inhibitory effe...

    Fatemeh Vazirian, Sara Samadi, Hossein Rahimi in Cancer Chemotherapy and Pharmacology (2022)

  2. Article

    Open Access

    HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions

    Adult T-cell leukemia/lymphoma (ATLL) is a lymphoproliferative disorder of HTLV-1-host interactions in infected TCD4+ cells. In this study, the HTLV-1 proviral load (PVL) and HBZ as viral elements and AKT1, BAD,

    Hanieh Tarokhian, Hossein Rahimi, Arman Mosavat, Abbas Shirdel in BMC Cancer (2018)

  3. No Access

    Article

    JAK2 V617F Mutation in Adult T Cell Leukemia-Lymphoma

    Adult T cell Leukemia/lymphoma (ATL) is a mature T-cell neoplasm that has strong association with the human T-lymphotropic virus type 1 (HTLV-I) infection. This infection is endemic in our region (north easter...

    Hossein Ayatollahi, Mohammad Hadi Sadeghian in Indian Journal of Hematology and Blood Tra… (2016)

  4. No Access

    Article

    Modified Irinotecan Plus Cisplatin and Dexamethasone (ICD) Combination Chemotherapy as Salvage Chemotherapy for Patients with Relapsed/Refractory Diffuse Large Cell Lymphoma

    About 50 % of patients with diffuse large cell lymphoma are candidate for salvage chemotherapy followed by bone marrow transplantation in the selected patients. In the current study we evaluated modified ICD (...

    Mojtaba Ghadiany, Mohammad Foratyazdi in Indian Journal of Hematology and Blood Tra… (2014)